Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 197,533 | 58,212 | 25,563 | 35,098 | 35,412 |
| Marketable Securities | 154,773 | 182,809 | 210,658 | 167,823 | 182,750 |
| Receivables | N/A | 2,096 | 537 | 229 | 3,637 |
| TOTAL | $357,480 | $249,923 | $242,199 | $207,519 | $225,998 |
| Non-Current Assets | |||||
| PPE Net | 2,824 | 3,900 | 5,216 | 6,906 | 7,368 |
| Other Non-Current Assets | 5,980 | 6,895 | 10,279 | 12,260 | 1,634 |
| TOTAL | $8,804 | $10,795 | $15,495 | $19,166 | $9,002 |
| Total Assets | $366,284 | $260,718 | $257,694 | $226,685 | $235,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,592 | 1,164 | 2,757 | 3,638 | 4,788 |
| Accrued Expenses | 9,052 | 7,694 | 8,726 | 9,551 | 9,231 |
| TOTAL | $13,048 | $11,044 | $13,675 | $16,725 | $19,199 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 934 | 5,180 |
| Other Non-Current Liabilities | 4,236 | 6,640 | 8,826 | 11,018 | 4,262 |
| TOTAL | $4,236 | $6,640 | $8,826 | $11,018 | $4,262 |
| Total Liabilities | $17,284 | $17,684 | $22,501 | $27,743 | $23,461 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,600 | 53,979 | 61,935 | 61,759 | 40,637 |
| Common Shares | 67 | 54 | 62 | 52 | 41 |
| Retained earnings | -594,278 | -519,398 | -509,673 | -412,338 | -302,467 |
| Other shareholders' equity | 174 | 130 | -136 | -797 | -397 |
| TOTAL | $349,000 | $243,034 | $235,193 | $198,942 | $211,539 |
| Total Liabilities And Equity | $366,284 | $260,718 | $257,694 | $226,685 | $235,000 |